UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000006742
Receipt number R000007966
Scientific Title Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II study
Date of disclosure of the study information 2011/11/20
Last modified on 2021/05/25 15:54:57

No. Disposal Last modified on Item of update
1 Insert 2011/11/17 20:58:02
2 Update 2012/02/01 10:01:50 Organization
Organization
Division name
Division name
Address
Address
TEL
Institute
Institute
Organization1
Address1
3 Update 2012/02/01 10:04:03 Organization
Organization
Category of Funding Organization
4 Update 2012/02/01 10:05:16 Last name of contact person
Last name of contact person
5 Update 2016/07/06 16:39:22 UMIN ID1
6 Update 2017/06/24 15:19:23 Recruitment status
Anticipated trial start date
7 Update 2021/05/24 13:07:44 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Zip code
Email
Name of person sending information
Name of person sending information
Address
Address
TEL
Email
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
8 Update 2021/05/24 13:10:02 Date of IRB
Last follow-up date
9 Update 2021/05/24 13:10:43 Number of participants that the trial has enrolled
10 Update 2021/05/25 15:54:57 UMIN ID2